Eurasian Hematology-Oncology Group

Draft Program

Hematology Specialist Association & MD Anderson Cancer Center Annual Meeting

7.50 - 8.00 Introduction

ALL SESSION

8.00 - 8.20 Biology of ALL - TBA

8.20 - 8.40 Frontline Therapy - Hagop Kantarjian

8.40 - 9.00 Management of Relapsed/Refractory ALL - Elias Jabbour

CML SESSION

9.00 - 9.20 Frontline CML Management - Hagop Kantarjian

9.20 - 9.40 Management of Relapsed/Refractory CML and Advanced Phases - Elias Jabbour

9.40 - 10.00 Treatment-Free Remission Where and When? - Giuseppe Saglio

10.00 - 10.20 Coffee Break

MDS SESSION

10.20 - 10.40 Management of Lower-Risk MDS - Tapan Kadia

10.40 - 11.00 Management of Higher-Risk MDS - Guillermo Garcia-Manero

AML SESSION

11.00 - 11.20 How I Treat AML - Farhad Ravandi

11.20 - 11.35 Molecular Biology and AML Risk Classification - TBA

11.35 - 11.50 Biology of AML and BCL2-Inhibitors - TBA

11.50 - 12.05 Elderly AML Management - Tapan Kadia

12.05 - 12.20 Novel Agents in AML - Farhad Ravandi

12.20 - 13.30 Lunch Break

CLL SESSION

13.30 - 13.50 How I Treat CLL: State of the Art - Susan O’Brien

13.50 - 14.10 Management of Relapsed/Refractory Disease: Novel Agents - Susan O’Brien

MPN SESSION

14.10 - 14.30 How I Treat MF - TBA

14.30 - 14.50 How I Treat PV - TBA

14.50 - 15.10 Coffee Break

MM SESSION

15.10 - 15.35 How I Treat Newly Diagnosed MM - TBA

15.35 - 16.00 Management of Relapsed/Refractory - TBA

LYMPHOMA SESSION

16.00 - 16.20 How I Treat Follicular Lymphoma - TBA

16.20 - 16.40 How I Treat Large Cell Lymphoma - TBA

16.40 - 17.00 How I Treat Hodgkin Disease - TBA

17.00 - 17.10 Closing Remarks and Adjourn